Results 231 to 240 of about 69,426 (314)

Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview

, 2020
Sandra Rodríguez, A. Muñoz, Rosa‐Helena Bustos, Diego Jaimes   +3 more
openalex   +1 more source

Knowledge, attitude, and practice regarding pharmacovigilance among hospital pharmacists in China. [PDF]

Ther Adv Drug Saf
Cheng Y, Qiu T, Zhang X, Zhou Q, Li X, Song A, Shen Q, Liu F.   +7 more
europepmc   +1 more source

Multidimensional Assessment of Neurological Adverse Reactions Related to PD‐1 Inhibitors: A Real‐World Pharmacovigilance Study

CNS Neuroscience &Therapeutics, Volume 32, Issue 1, January 2026.
This pharmacovigilance study systematically analyzed PD‐1 inhibitor–associated neurological adverse events using FAERS data from 2014 to 2024. Central nervous system toxicities, including encephalitis and brainstem encephalitis, were most prominent. Older age, female sex, specific cancer types, and combination therapies increased the risk, with most ...
Xiaofeng Hu, Xiaoli Wang, Bufu Tang, Dehuan Zhang, Rongbing Cai, Hui Jiang, Yaling Lin, Yiheng Song, Yiou Wang, Hairuo Huang, Dandan Guo, Xubin Sun, Hongjie Fan   +12 more
wiley   +1 more source

Perceptions of Libyan Community Pharmacists on Pharmacovigilance Activities

, 2020
Ahmed Atia, Amal Botto, Safia Alarbi
openalex   +1 more source

Pharmacovigilance Insights Into Immune Checkpoint Inhibitor‐Induced Risk of Paraneoplastic Syndrome: A Large‐Scale Real World Study

CNS Neuroscience &Therapeutics, Volume 32, Issue 1, January 2026.
Immune checkpoint inhibitors are associated with rare but severe paraneoplastic syndromes, particularly in lung cancer patients. PS onset shows a bimodal pattern, with increased severity seen in combination therapies like durvalumab plus tremelimumab.
Bufu Tang, Xin Song, Yiting Sun, Juncheng Wan, Wenlu Hu, Yifei Ma, Yihang Lin, Jian Zhang, Yiou Wang, Hongyang Feng, Peng Luo, Dandan Guo, Xudong Qu   +12 more
wiley   +1 more source

Impact of Pharmacovigilance Sensitization on Knowledge and Attitude Amongst Medical and Paramedical Students in a Tertiary Care Teaching Hospital: A Questionnaire-Based Study. [PDF]

Cureus
Thakare V, Jain M, Reza M, Patil A, Langade D.   +4 more
europepmc   +1 more source

Sex-Specific Safety Signals of Trelegy Ellipta: A FAERS Pharmacovigilance Analysis [PDF]

Josef Yayan, Christian Biancosino, M. Krüger, Kurt Rasche   +3 more
openalex   +1 more source

Quantitative Systems Toxicology Predicts Ivacaftor‐Induced Oxidative Stress Contributes to CFTR Modulator Hepatotoxicity

Clinical Pharmacology &Therapeutics, Volume 119, Issue 1, Page 208-218, January 2026.
Cystic fibrosis (CF) is a chronic hereditary disease that affects tens of thousands of people worldwide. The introduction of CFTR modulator therapies such as elexacaftor/tezacaftor/ivacaftor (ETI) has significantly improved the quality of life of people with CF.
Alan Shi, Cole Cornwell, Kyunghee Yang, Paul M. Beringer   +3 more
wiley   +1 more source

Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance. [PDF]

Cancers (Basel)
Pina-Cabral T, Pereira J, Paulo-Fernandes J, Silva M, Fontes-Sousa M, Anacleto M, Lobo-Martins S, Mirco A, Miranda H, Martins A, Cavaco P.   +10 more
europepmc   +1 more source

Association Discovery Approach in Healthcare Big Data to Identify Drug Safety and Drug Repurposing Signals

Clinical Pharmacology &Therapeutics, Volume 119, Issue 1, Page 228-240, January 2026.
Data science approaches have been increasingly implemented in healthcare big data to evaluate the safety and effectiveness of drugs. Association discovery is a data mining approach that finds potentially associated elements in high‐dimensional data. We present a novel implementation of the association discovery approach in longitudinal healthcare data ...
George S. Q. Tan, Lynn Miller, Sam Wade, Jenni Ilomäki, Dickson Lukose, Jia Rong, Geoffrey I. Webb   +6 more
wiley   +1 more source